Induction of cytotoxic T-lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin

Immunology

Volumn 124, Issue 2, 2008, Pages 155-165

  Sawai, Toshihiro ^a   Itoh, Yasushi ^a   Ozaki, Hiroichi ^b   Isoda, Norikazu ^c   Okamoto, Kiyoko ^a   Kashima, Yoshitaka ^a   Kawaoka, Yoshihiro ^d,e   Takeuchi, Yoshihiro ^a   Kida, Hiroshi ^c   Ogasawara, Kazumasa ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Cytotoxic T lymphocyte; H5N1; Virus library; Virus particle

Indexed keywords

ETHER; FORMALDEHYDE; INFLUENZA VACCINE; VIRUS NUCLEOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; AVIAN INFLUENZA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG RESPONSE; INFLUENZA VIRUS A H5N1; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS INACTIVATION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS STRAIN;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CYTOTOXICITY, IMMUNOLOGIC; FORMALDEHYDE; FREUND'S ADJUVANT; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INTERFERON-ALPHA; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, INACTIVATED; VIRUS REPLICATION;

EID: 43749100872     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02745.x     Document Type: Article

References (39)

1. Doherty PC, Turner SJ, Webby RG, Thomas PG. Influenza and the challenge for immunology. Nat Immunol 2006 7 : 449 55.
2. Russell CJ, Webster RG. The genesis of a pandemic influenza virus. Cell 2005 123 : 368 71.
3. Stieneke-Grober A, Vey M, Angliker H, Shaw E, Thomas G, Roberts C, Klenk HD, Garten W. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J 1992 11 : 2407 14.
4. Tran TH, Nguyen TL, Nguyen TD et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004 350 : 1179 88.
5. Uiprasertkul M, Puthavathana P, Sangsiriwut K et al. Influenza A H5N1 replication sites in humans. Emerg Infect Dis 2005 11 : 1036 41.
6. Pulendran B, Ahmed R. Translating innate immunity into immunological memory: implications for vaccine development. Cell 2006 124 : 849 63.
7. Reiss CS, Schulman JL. Cellular immune responses of mice to influenza virus vaccines. J Immunol 1980 125 : 2182 8.
8. + T cells. J Exp Med 1991 174 : 875 80.
9. Bender BS, Croghan T, Zhang L, Small PA Jr. Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med 1992 175 : 1143 5.
10. Armerding D, Rossiter H, Ghazzouli I, Liehl E. Evaluation of live and inactivated influenza A virus vaccines in a mouse model. J Infect Dis 1982 145 : 320 30.
11. Blazevic V, Trubey CM, Shearer GM. Comparison of in vitro immunostimulatory potential of live and inactivated influenza viruses. Hum Immunol 2000 61 : 845 9.
12. Takada A, Matsushita S, Ninomiya A, Kawaoka Y, Kida H. Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. Vaccine 2003 21 : 3212 8.
13. +-T- lymphocyte immunodominance hierarchy than infectious virus. J Virol 2003 77 : 4679 84.
14. McMichael AJ, Gotch F, Cullen P, Askonas B, Webster RG. The human cytotoxic T cell response to influenza A vaccination. Clin Exp Immunol 1981 43 : 276 84.
15. + T cells by immunization with killed influenza virus and effect of chorea toxin B subunit. Vaccine 1993 11 : 1205 13.
16. +-T-cell-deficient mice. J Virol 2002 76 : 12388 93.
17. + T cell populations. Nat Immunol 2005 6 : 382 9.
18. Nelson D, Bundell C, Robinson B. In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes. J Immunol 2000 165 : 6123 32.
19. Takada A, Kuboki N, Okazaki K et al. Avirulent avian influenza virus as a vaccine strain against a potential human pandemic. J Virol 1999 73 : 8303 7.
20. Ogasawara K, Naruse H, Itoh Y, Gotohda T, Arikawa J, Kida H, Good RA, Onoé K. A strategy for making synthetic peptide vaccines. Proc Natl Acad Sci USA 1992 89 : 8995 9.
21. Isoda N, Sakoda Y, Kishida N, Bai G-R, Matsuda K, Umemura Kida H. Pathogenicity of a highly pathogenic avian influenza virus, A/chicken/Yamaguchi/ 7/04 (H5N1) in different species of birds and mammals. Arch Virol 2006 151 : 1267 79.
22. Nakamura I, Kajino K, Bamba H, Itoh F, Takikita M, Ogasawara K. Phenotypic stability of mature dendritic cells tuned by TLR or CD40 to control the efficiency of cytotoxic T cell priming. Microbiol Immunol 2004 48 : 211 9.
23. Ito D, Ogasawara K, Iwabuchi K, Inuyama Y, Onoé K. Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb. J Immunol 2000 164 : 1230 5.
24. + CTLs during functional maturation. J Immunol 2005 174 : 5959 67.
25. Ninomiya A, Ogasawara K, Kajino K, Takada A, Kida H. Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice. Vaccine 2002 20 : 3123 9.
26. Kida H, Brown LE, Webster RG. Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus. Virology 1982 122 : 38 47.
27. Bridges CB, Harper SA, Fukuda K, Uyeki TM, Cox NJ, Singleton JA. Advisory Committee on Immunization Practices. Prevention and control of influenza. Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2003 52 : 1 34 quiz CE1-4. Erratum in : MMWR Morb Mortal Wkly Rep 52 : 526.
28. Proietti E, Bracci L, Puzelli S et al. Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model. J Immunol 2002 169 : 375 83.
29. + T cells stimulated by virus-induced type I interferon. Nat Immunol 2003 4 : 1009 15.
30. + T cells expressing gamma interferon. J Virol 2002 76 : 4886 90.
31. + T-cell-independent immunoglobulin responses by inactivated influenza virus. J Virol 2000 74 : 4999 5005.
32. Ennis FA, Cruz J, Jameson J, Klein M, Burt D, Thipphawong J. Augmentation of human influenza A virus-specific cytotoxic T lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS). Virology 1999 259 : 256 61.
33. Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 2007 315 : 1398 400.
34. Noda T, Sagara H, Yen A, Takada A, Kida H, Cheng RH, Kawaoka Y. Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature 2006 439 : 490 2.
35. Cheong HK, Cheong C, Lee YS, Seong BL, Choi BS. Structure of influenza virus panhandle RNA studied by NMR spectroscopy and molecular modeling. Nucleic Acids Res 1999 27 : 1392 7.
36. Qin HY, Sadelain MW, Hitchon C, Lauzon J, Singh B. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J Immunol 1993 150 : 2072 80.
37. Ulaeto D, Lacy PE, Kipnis DM, Kanagawa O, Unanue ER. A T-cell dormant state in the autoimmune process of nonobese diabetic mice treated with complete Freund's adjuvant. Proc Natl Acad Sci USA 1992 89 : 3927 31.
38. Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol 2001 167 : 1081 9.
39. Kida H, Sakoda Y. Library of influenza virus strains for vaccine and diagnostic use against highly pathogenic avian influenza and human pandemics. Dev Biol (Basel) 2006 124 : 69 72.